All

API

FDF

Price

Services

Excipients

Enquiries

Find

Active Pharmaceutical Ingredients
Finished Drug Formulations
Price
Excipients
Services
Marketplace

Market Place

Post Enquiry

Grow Your Pharma Business Digitally

Wavelength-Pharmaceuticals-Insert

X

Find Clinical Drug Development Pipelines & Deals | PipelineProspector

All Data

Filters

refresh

×

FILTER DATA :

News Type

Company

Product Type

Deal Size

Upfront Payment

refresh

Product Type

Companies

Aptorum

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Hong Kong

Post An Enquiry

CAMBODIA PHAR-MED 2020

Participation Not Confirmed

Update your events

Aptorum Group Announces Pricing of $10 Million Registered Direct Offering

Contact the Supplier

Lead Product(s): SACT-1

Therapeutic Area: Oncology Product Name: Undisclosed

Highest Development Status: Phase I/ Phase II Product Type: Undisclosed

Partner/Sponsor/Collaborator: Alliance Global Partners

Deal Size: $10.0 million Upfront Cash: Undisclosed

Deal Type: Public Offering February 26, 2020

Details:

Net proceeds from the offering will fund the continued research and development of its leading therapeutic candidates (including SACT-1 and ALS-4) into their respective clinical phases.